INVASIVE DUCTAL BREAST CARCINOMA: CORRELATION OF AXL AND Β-CATENIN IMMUNOHISTOCHEMICAL EXPRESSION WITH TUMOR AGGRESSIVITY

• Autor(a) principal: Gennaro, Lucas
• Data de Publicação: 2022
• Outros Autores: Ribas , Carmen Austrália Paredes Marcondes, Ramos, Rafael Koerich, Ariede, Bruno Luiz, Waaga-Gasser, Ana Maria, Collaço, Luiz Martins, Sigwalt, Marcos Fabiano, Ribas Filho, Jurandir Marcondes, Kubrusly, Luiz Fernando
• Tipo de documento: preprint
• Idioma: por
• Título da fonte: SciELO Preprints
• Texto Completo: https://preprints.scielo.org/index.php/scielo/preprint/view/4427
• topic: Imunoistoquímica; AXL; β-catenina; Immunohistochemistry; AXL; β-Catenin

Introduction: Invasive ductal carcinoma corresponds to the most common histological type of the breast, coexisting with different forms of clinical evolution, histological grading, expression of certain tissue markers and genomic profiles that seek a better understanding of the disease. Objectives: To analyze the correlation of β-catenin and AXL markers with tumor aggressiveness, with reference to overall survival, tumor progression and histopathological prognostic factors. Methods: A study of 101 samples of invasive ductal mammary carcinoma was performed. Those with a diagnosis of ductal type, initially submitted to biopsy or definitive surgical treatment, were included. For control purposes, 20 samples of intraductal carcinoma, 35 of breast fibroadenoma and 10 of breast tissue without any alteration were included. Those undergoing neoadjuvant chemotherapy, those without a tumor sample prior to chemotherapy, those lost to follow-up, and those with incomplete data, were excluded. Results: When the β-catenin expression was analyzed, it was negative. As for AXL, different degrees of expression were observed without statistical significance between them. Conclusion: When analyzing invasive ductal breast adenocarcinoma in TMA, there was no correlation in the expression of ß-Catenin and AXL when compared to overall survival, tumor progression and histological grade.